You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 162 No. 8, August 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  The Pediatric Forum
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Pediatrics
 •Adolescent Medicine
 •Psychiatry
 •Attention Deficit Hyperactivity Disorder
 •Public Health
 •Injury Prevention & Control
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Long-Acting OROS Methylphenidate on Routine Driving in Young Adults With Attention-Deficit/Hyperactivity Disorder

Daniel J. Cox, PhD; Amori Yee Mikami, PhD; Brian S. Cox, BS; Margaret Taylor Coleman, BA; Aamir Mahmood, MD; Ajay Sood, MD; Melissa Moore, MD; Roger Burket, MD; R. Lawrence Merkel, MD, PhD

Arch Pediatr Adolesc Med. 2008;162(8):793-794.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Young drivers with attention deficit/hyperactivity disorder (ADHD), because of their inattention and impulsivity, have more vehicular collisions, citations, and related injuries than drivers without ADHD.1 In laboratory studies, methylphenidate has improved simulated driving in this population.2 However, it is unknown whether long-acting methylphenidate improves routine driving while youth negotiate cell phones, music systems, teenaged passengers, and rushed schedules.

We report on the routine driving safety of 2 young drivers who at the time of recruitment were not taking ADHD medication. However, 2 years previously they participated in a laboratory study2 in which they responded to 72 mg of osmotic-release oral system (OROS) methylphenidate hydrochloride daily.

Methods

After signing a consent form approved by our institutional review board, study . . . [Full Text of this Article]


Results

Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.